B. Riley Wealth Management’s Avadel Pharmaceuticals AVDL Stock Holding History

B. Riley Wealth Management’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$32	Buy	+13,000	New	+$53.4K	﹤0.01%	738
2015 Q3	–	Sell	-350	Closed	-$7K	–	183
2015 Q2	$7K	Hold	350	–	–	0.01%	800
2015 Q1	$6K	Hold	350	–	–	﹤0.01%	821
2014 Q4	$5K	Hold	350	–	–	﹤0.01%	836
2014 Q3	$5K	Hold	350	–	–	﹤0.01%	889
2014 Q2	$5K	Buy	+350	New	+$4.22K	﹤0.01%	930

Other funds holding AVDL

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

GJL

Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

B. Riley Wealth Management's AVDL Position: Q2 2022 in Review

B. Riley Wealth Management opened a new position in Avadel Pharmaceuticals (AVDL) in Q2 2022: 13,000 shares worth $32. The stake represents ﹤0.01% of the portfolio and ranks #738 among its holdings. This is a return to the name: B. Riley Wealth Management previously reported a position in AVDL as recently as Q2 2015.

B. Riley Wealth Management first reported a position in AVDL in Q2 2014 and has held it in 6 quarters since. The position peaked at $7K in Q2 2015. 82 funds tracked by Wall St. Rank hold AVDL as of Q2 2022.

B. Riley Wealth Management held 13,000 shares of Avadel Pharmaceuticals worth $32 as of Q2 2022.
Avadel Pharmaceuticals was a new B. Riley Wealth Management position in Q2 2022.
Avadel Pharmaceuticals made up ﹤0.01% of B. Riley Wealth Management's portfolio in Q2 2022, its #738 holding.
B. Riley Wealth Management first reported a position in Avadel Pharmaceuticals in Q2 2014 and has held it in 6 quarters since.
B. Riley Wealth Management's Avadel Pharmaceuticals position peaked at $7K in Q2 2015.
82 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q2 2022.

Based on B. Riley Wealth Management's 13F filing for Q2 2022, filed 9 Sep 2022.